PRICE HISTORY.
Use the left and right arrow keys to inspect dated observations. Home selects the first observation and End selects the latest.
Key numbers
Published fundamentals and the date each figure was recorded.
Arch Pharmalabs describes Contract Research and Manufacturing Services (CRAMS) as a growing business vertical. It says its capabilities cover route selection, process development and optimization, analytical development, stability studies, safety studies, scale-up, technology transfer, clinical-trial manufacturing and commercial manufacturing for US and EU regulatory requirements. The company says it can manage complex reactions at scales from a few grams to several tonnes and has used proprietary bio-catalytic or enzymatic technology to develop a manufacturing route for key advanced intermediates. Arch states that it targets projects from large innovator firms that use customized research and manufacturing services. These projects include work in drug development, customized synthesis of drug intermediates, small-scale API manufacturing for clinical trials, and commercial-scale manufacture of patent-protected APIs. It also describes custom chemical synthesis and contract manufacturing of on-patent APIs and intermediates as parts of its CRAMS portfolio.
About this company
Arch Pharmalabs Limited is a pharmaceutical manufacturing company focused on producing Active Pharmaceutical Ingredients (APIs) and intermediates, which are key raw materials used in making medicines. The company also offers contract development and manufacturing services (commonly known as CRAMS), supporting global pharma companies across the drug lifecycle—from early-stage development to commercial production. Established in 1993 and headquartered in Mumbai, the company operates multiple manufacturing facilities in India and caters to both domestic and international markets, including regulated regions like the US and Europe.
COMPANY REGISTRY · ON FILE
THE CREW · BOARD & MANAGEMENT
COMMON QUESTIONS.
Is Arch Pharmalabs Limited listed on the stock exchange?+
No. As of 3 September 2026, Arch Pharmalabs Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
What is the Arch Pharmalabs Limited unlisted share price?+
As of 3 September 2026, the indicative unlisted share price of Arch Pharmalabs Limited is ₹85 per share. This is an over-the-counter reference price, not a stock-exchange quote.
What indicative minimum amount is displayed for Arch Pharmalabs Limited unlisted shares?+
The displayed unit count is 120 share(s); at the indicative price of about ₹85, the displayed amount is approximately ₹10,200. This is a display convention, not evidence of inventory, an order minimum or a quote.
What is the ISIN of Arch Pharmalabs Limited?+
The recorded ISIN of Arch Pharmalabs Limited is INE182F01017. An ISIN is a 12-character security identifier. Verify it against the issuer and the relevant depository record before using it for any transfer or documentation.
Is trading in Arch Pharmalabs Limited unlisted shares legal in India?+
Unlisted shares can be transferred off-market in India, but the legal, tax and compliance position depends on the security, parties, documents and current rules. Verify the intermediary, issuer restrictions and applicable requirements before proceeding.
Is there a lock-in period for unlisted shares?+
A post-listing lock-in may apply under the rules in force at the time. The period and any exemptions can depend on the holder and acquisition, so check the current regulation and the issuer's offer documents rather than relying on a generic period.
Do you guarantee returns?+
No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes. This is information only, not investment advice.